Thomas D. Carey is Director at EXACT SCIENCES CORP (EXAS). They have made 7 open-market trades across 1 company since 2001, most recently 2026-06-18.
CIK 0001574633
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $94K since 2017, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EXAS | SELL | 2020-07-31 | 2020-08-04 | $94.00 | $2.9M | -7.9% | -17.6% | +31.5% |
| EXAS | SELL | 2019-07-31 | 2019-08-02 | $117.58 | $1.7M | +6.1% | +6.0% | -21.9% |
| EXAS | SELL | 2019-02-28 | 2019-03-01 | $96.00 | $720K | +2.0% | -2.9% | +9.2% |
| EXAS | SELL | 2018-07-30 | 2018-08-01 | $58.86 | $403K | +2.1% | +55.2% | +33.4% |
| EXAS | SELL | 2018-04-10 | 2018-04-12 | $39.71 | $663K | +2.7% | +13.9% | +36.8% |
| EXAS | BUY | 2017-08-17 | 2017-08-18 | $37.71 | $94K | +7.1% | +11.6% | +53.7% |
| EXAS | SELL | 2001-06-02 | 2021-06-03 | $108.11 | $1.8M | +12.9% | +12.3% | -2.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.